Dianne Dalton

Dianne Dalton, MPA, has extensive experience in the clinical research field, currently serving as President of Clinical Research Consulting, Incorporated since June 2007, focusing on inspection readiness for FDA and EMA audits and medical writing. Dianne has also been a consultant for Daiichi Sankyo, Inc. and La Jolla Pharmaceutical Company since 2015, specializing in GCP auditing and compliance for phase III studies. Additional roles include Quality Assurance Consultant at Intercept Pharmaceuticals and consulting positions at InClin, Inc. and Berg Pharma, as well as a Clinical Program Manager at UC San Diego with over 20 years in clinical development. Dianne's academic credentials include a Master’s in Public Administration from the University of San Francisco and Bachelor’s degrees in Finance and Biology from East Carolina University and Trinity, respectively.